Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

268 recalls, newest first

Class II · Moderate risk

Alcohol Antiseptic 80%

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Ongoing cGMP deviation A.P. Nonweiler D-1142-2022
Class II · Moderate risk

Erythromycin Topical Gel USP

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-053-68 D-0851-2022
Class II · Moderate risk

Betamethasone Dipropionate Ointment USP

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-996-65 D-0850-2022
Class II · Moderate risk

Lidocaine Prilocaine Cream USP

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-054-66 D-0849-2022
Class II · Moderate risk

Lidocaine Hydrochloride Topical Solution USP 4%

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-977-64 D-0848-2022
Class II · Moderate risk

Halobetasol Propionate Ointment 0.05% Net Wt.

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-998-67 D-0847-2022

Recalls by year